Trial search - ClinicalTrials.eu

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

Study on Doxorubicin Hydrochloride and Trabectedin for Patients with Recurrent Ovarian Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Ovarian cancer
Investigated Drugs:
- Trabectedin
- Doxorubicin Hydrochloride
Study of Relacorilant and Nab-Paclitaxel for Patients with Advanced, Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer

Not recruiting

3 1 1 1
Investigated Drugs:
- Relacorilant
- Paclitaxel Albumin-Bound
Study of Fadraciclib in Adults with Advanced Solid Tumors (Including Breast, Colorectal, Endometrial, Ovarian, Biliary Tract, and Liver Cancer) and Lymphoma

Not recruiting

1 1 1
Investigated Diseases:
Investigated Drugs:
- Fadraciclib
Study of Nemvaleukin Alfa and Pembrolizumab for Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.

Not recruiting

3 1 1 1
Investigated Diseases:
Investigated Drugs:
+4
Study of Nivolumab alone or combined with Ipilimumab for patients with advanced solid tumors (breast, gastric, pancreatic, lung, bladder, or ovarian cancer)

Not recruiting

1 1 1 1
Investigated Diseases:
Investigated Drugs:
- Ipilimumab
- Nivolumab
Study on the Safety and Tolerability of KAND567 and Carboplatin for Women with Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Not recruiting

1 1 1 1
Investigated Diseases:
- Ovarian cancer
Investigated Drugs:
- (2R)-2-[[2-Amino-5-[(1S)-1-Phenylethyl]Sulfanyl-[1,3]Thiazolo[4,5-D]Pyrimidin-7-Yl]Amino]-4-Methylpentan-1-Ol Hydrochloride
- Carboplatin
Study on the Effectiveness of Durvalumab, Olaparib, and Bevacizumab in Patients with Newly Diagnosed Advanced Ovarian Cancer

Not recruiting

3 1 1
Investigated Diseases:
- Ovarian cancer
Investigated Drugs:
+6
Study of Pembrolizumab for Patients with Recurrent, Platinum-Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
- Pembrolizumab
Study of Olaparib, Durvalumab and UV1 combination as maintenance treatment for patients with recurrent ovarian cancer who do not have BRCA mutations

Not recruiting

2 1 1 1
Investigated Diseases:
- Ovarian cancer
Investigated Drugs:
+3
Study on Carboplatin, Paclitaxel, Bevacizumab, and Rucaparib for Advanced Ovarian, Primary Peritoneal, and Fallopian Tube Cancer Patients

Not recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:

Opportunities for Healthy Volunteers

Matched clinical trials

We use cookies